Related Experiment Video
Updated: Apr 28, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
LncRNA PCAT18: Roles and Mechanisms in Human Cancers
Xiaohui Wang1, Henan Zhang1, Fang Chen1
1Hematology Laboratory, Shengjing Hospital of China Medical University, Shenyang, China.
None:
lncRNAs are a group of RNA molecules with over 200 nucleotides involved in many biological processes. The dysregulation of lncRNA has been covered in several processes related to carcinogenesis, such as proliferation, apoptosis, invasion, evasion, and metastasis of cancer cells. PCAT18 is a newly discovered non-coding RNA first described as an androgen-regulated gene and highly upregulated in PCa. Recent studies revealed that PCAT18 functions as a regulatory molecule in PCa, lung cancer, breast cancer, digestive cancer, and leukemia. With this, we review the molecular mechanism and clinical significance of PCAT18 in various cancers. This article is categorized under: RNA in Disease and Development > RNA in Disease.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-LTR Retrotransposons
piRNA - Piwi-interacting RNAs
Abnormal Proliferation
